Novacyt S.A.
ALNOV.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €19,630 | €11,579 | €21,040 | €95,780 |
| % Growth | 69.5% | -45% | -78% | – |
| Cost of Goods Sold | -€12,444 | €7,849 | €15,294 | €66,102 |
| Gross Profit | €32,074 | €3,730 | €5,746 | €29,678 |
| % Margin | 163.4% | 32.2% | 27.3% | 31% |
| R&D Expenses | €2,767 | €3,228 | €5,047 | €4,815 |
| G&A Expenses | €40,239 | €4,884 | €4,856 | €6,810 |
| SG&A Expenses | €41,526 | €5,878 | €9,682 | €13,835 |
| Sales & Mktg Exp. | €1,287 | €994 | €4,826 | €7,025 |
| Other Operating Expenses | €25,124 | €24,140 | €7,619 | €12,395 |
| Operating Expenses | €69,417 | €33,246 | €22,348 | €31,045 |
| Operating Income | -€37,343 | -€29,516 | -€16,602 | -€1,367 |
| % Margin | -190.2% | -254.9% | -78.9% | -1.4% |
| Other Income/Exp. Net | -€2,087 | €948 | €3,340 | -€1,933 |
| Pre-Tax Income | -€39,430 | -€28,568 | -€20,053 | -€9,829 |
| Tax Expense | -€732 | -€768 | €2,148 | -€101 |
| Net Income | -€41,758 | -€28,292 | -€22,201 | -€9,728 |
| % Margin | -212.7% | -244.3% | -105.5% | -10.2% |
| EPS | -0.59 | -0.4 | -0.31 | -0.14 |
| % Growth | -47.5% | -29% | -121.4% | – |
| EPS Diluted | -0.59 | -0.4 | -0.31 | -0.14 |
| Weighted Avg Shares Out | 70,626 | 70,626 | 70,626 | 70,626 |
| Weighted Avg Shares Out Dil | 70,626 | 70,626 | 70,626 | 70,626 |
| Supplemental Information | – | – | – | – |
| Interest Income | €3,034 | €735 | €782 | €33 |
| Interest Expense | €5,121 | €682 | €489 | €239 |
| Depreciation & Amortization | -€202 | €9,643 | €2,479 | €2,083 |
| EBITDA | -€34,309 | -€18,243 | -€11,677 | -€4,197 |
| % Margin | -174.8% | -157.6% | -55.5% | -4.4% |